Sally Agersborg

762 total citations
36 papers, 612 citations indexed

About

Sally Agersborg is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Sally Agersborg has authored 36 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Sally Agersborg's work include Cancer Genomics and Diagnostics (9 papers), AI in cancer detection (4 papers) and HER2/EGFR in Cancer Research (4 papers). Sally Agersborg is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), AI in cancer detection (4 papers) and HER2/EGFR in Cancer Research (4 papers). Sally Agersborg collaborates with scholars based in United States, Italy and Croatia. Sally Agersborg's co-authors include Kenneth S. K. Tung, Kristine M. Garza, Maher Albitar, Pascale Alard, Elizabeth Baker, P S Linsley, J A Ledbetter, Randolph J. Noelle, Wanlong Ma and Vincent Funari and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Sally Agersborg

35 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sally Agersborg United States	15	283	167	89	87	75	36	612
Karima Mrad Tunisia	15	117 0.4×	207 1.2×	133 1.5×	121 1.4×	53 0.7×	92	724
Amy Ly United States	16	225 0.8×	231 1.4×	291 3.3×	211 2.4×	149 2.0×	63	1.1k
Silje Fismen Norway	17	283 1.0×	135 0.8×	124 1.4×	32 0.4×	65 0.9×	25	666
Elena Lucas United States	15	203 0.7×	175 1.0×	139 1.6×	65 0.7×	40 0.5×	50	628
Nicole de Rosa United States	10	156 0.6×	379 2.3×	135 1.5×	48 0.6×	27 0.4×	15	541
Séverine Valmary‐Degano France	18	152 0.5×	213 1.3×	216 2.4×	75 0.9×	41 0.5×	59	812
Diana Tronik‐Le Roux France	17	553 2.0×	210 1.3×	252 2.8×	58 0.7×	63 0.8×	37	1.1k
Russell Keenan United Kingdom	13	263 0.9×	200 1.2×	212 2.4×	33 0.4×	24 0.3×	31	982
Paolo Peterlongo Italy	13	206 0.7×	231 1.4×	450 5.1×	125 1.4×	44 0.6×	31	1.0k
Erika Bongen United States	7	185 0.7×	42 0.3×	187 2.1×	55 0.6×	29 0.4×	7	456

Countries citing papers authored by Sally Agersborg

Since Specialization

Citations

This map shows the geographic impact of Sally Agersborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Agersborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Agersborg more than expected).

Fields of papers citing papers by Sally Agersborg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Agersborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Agersborg. The network helps show where Sally Agersborg may publish in the future.

Co-authorship network of co-authors of Sally Agersborg

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Agersborg. A scholar is included among the top collaborators of Sally Agersborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Agersborg. Sally Agersborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Albitar, Maher, Sally Agersborg, Noa Biran, et al.. (2025). Heterogeneity in the expression of GPRC5D between patients with multiple myeloma.. Journal of Clinical Oncology. 43(16_suppl). 7511–7511.

Albitar, Maher, Andrew Ip, Sally Agersborg, et al.. (2024). Using cell-free RNA in monitoring immune system and the demonstration of significant systemic deficiency in lymphoid and myeloid biomarkers in patients with cancer.. Journal of Clinical Oncology. 42(16_suppl). 3048–3048. 1 indexed citations

Albitar, Maher, et al.. (2024). Expanding the clinical utility of liquid biopsy by using liquid transcriptome and artificial intelligence. SHILAP Revista de lepidopterología. 6. 100270–100270. 7 indexed citations

Agersborg, Sally, et al.. (2024). Liquid biopsy for evaluating mutations and chromosomal aberrations in cerebrospinal fluid from patients with primary or metastatic CNS tumors. SHILAP Revista de lepidopterología. 6. 100281–100281. 3 indexed citations

Zhang, Hong, et al.. (2024). Expression of alternatively spliced PD-L1 RNA with skipping of transmembrane domain.. Journal of Clinical Oncology. 42(16_suppl). e14596–e14596. 1 indexed citations

Baker, Robin J., Sally Agersborg, Thomas K. Lee, et al.. (2023). Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care system. Breast Cancer Research and Treatment. 203(2). 281–289. 2 indexed citations

Magnan, Chr̀istophe, et al.. (2020). A Highly Sensitive and Specific Gene Fusion Algorithm Based on Multiple Fusion Callers and an Ensemble Machine Learning Approach. Blood. 136(Supplement 1). 12–13. 3 indexed citations

Agersborg, Sally, Sucha Sudarsanam, Lawrence M. Weiss, et al.. (2018). Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification. Breast Cancer Research and Treatment. 170(2). 321–328. 32 indexed citations

Ma, Wanlong, et al.. (2017). IDH1 and IDH2 : Founding or Progressor Mutations in Myeloid Neoplasms. Blood. 130. 405–405. 2 indexed citations

10.

Ma, Wanlong, Steven G. Brodie, Sally Agersborg, Vincent Funari, & Maher Albitar. (2017). Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits. Molecular Diagnosis & Therapy. 21(5). 571–579. 17 indexed citations

11.

Ma, Wanlong, et al.. (2016). Deep Sequencing of Cell-Free Peripheral Blood DNA as a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome. Genetic Testing and Molecular Biomarkers. 20(7). 341–345. 9 indexed citations

12.

Nassar, Aziza, Cynthia Cohen, Sally Agersborg, et al.. (2011). Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimens.. Archives of Pathology & Laboratory Medicine. 135(7). 896–902. 22 indexed citations

13.

Nassar, Aziza, Cynthia Cohen, Maher Albitar, et al.. (2011). Reading Immunohistochemical Slides on a Computer Monitor—A Multisite Performance Study Using 180 HER2-stained Breast Carcinomas. Applied immunohistochemistry & molecular morphology. 19(3). 212–217. 15 indexed citations

14.

Setiady, Yulius Y., Sally Agersborg, Eileen T. Samy, Janet E. Lewis, & Kenneth S. K. Tung. (2005). Neonatal Autoimmune Disease: Influence of CD4⁺CD25⁺Regulatory T Cells. International Reviews of Immunology. 24(3-4). 227–245. 7 indexed citations

15.

Alard, Pascale, Claire Thompson, Sally Agersborg, et al.. (2001). Endogenous Oocyte Antigens Are Required for Rapid Induction and Progression of Autoimmune Ovarian Disease Following Day-3 Thymectomy. The Journal of Immunology. 166(7). 4363–4369. 34 indexed citations

16.

Agersborg, Sally, Kristine M. Garza, & Kenneth S. K. Tung. (2001). Intestinal parasitism terminates self tolerance and enhances neonatal induction of autoimmune disease and memory. European Journal of Immunology. 31(3). 851–859. 32 indexed citations

17.

Tung, Kenneth S. K., et al.. (2001). Regulatory T‐cell, endogenous antigen and neonatal environment in the prevention and induction of autoimmune disease. Immunological Reviews. 182(1). 135–148. 33 indexed citations

18.

Lou, Ya‐Huan, Kwan Kyu Park, Sally Agersborg, Pascale Alard, & Kenneth S. K. Tung. (2000). Retargeting T Cell-Mediated Inflammation: A New Perspective on Autoantibody Action. The Journal of Immunology. 164(10). 5251–5257. 42 indexed citations

19.

Garza, Kristine M., Sally Agersborg, Elizabeth Baker, & Kenneth S. K. Tung. (2000). Persistence of Physiological Self Antigen Is Required for the Regulation of Self Tolerance. The Journal of Immunology. 164(8). 3982–3989. 68 indexed citations

20.

Agersborg, Sally, et al.. (1996). The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells.. The Journal of Experimental Medicine. 183(3). 801–810. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact